Gangolli Julian S

Director at KRYS; President, North America at GW PHARMACEUTICALS PLC; CVP & Pres, North America at ALLERGAN INC

Sold, on record
$27.4M
Dollars the filings state
Form 4 sales
5
Latest May 20, 2024
Form 144 notices
1
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale ALLERGAN INCUnusual
    Nov 28, 2012 2012

    Sold 90,000 shares at $91.89 ($8.3M)

    Gangolli Julian S, CVP & Pres, North America

    Sold 85.1% of holdings ($9.7M position)15,781 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ALLERGAN INCUnusual
    Dec 27, 2013 +394 days

    Sold 52,500 shares at $110.05 ($5.8M)

    Gangolli Julian S, CVP & Pres, North America

    Sold 86.7% of holdings ($6.7M position)8,047 shares leftFiling

  3. 3 Form 4 sale GW PHARMACEUTICALS PLCPlan not stated
    Feb 26, 2019 +1887 days

    Sold 6,000 shares at $12.45 ($75k)

    Gangolli Julian S, President, North America

    Sold 5.3% of holdings ($1.4M position)106,548 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale GW PHARMACEUTICALS PLCUnusual
    May 10, 2019 +73 days

    Sold 671,928 shares at $14.84 ($10M)

    Gangolli Julian S, President, North America

    Sold 86.3% of holdings ($11.6M position)106,548 shares leftFiling

  5. 5 Form 144 notice KRYSNotice
    May 20, 2024 +1837 days

    Filed to sell 20,000 shares ($3.3M)

    Gangolli Julian S, Director

    No 10b5-1 planFirst sale on recordFiling

  6. 6 Form 4 sale KRYSUnusual
    May 20, 2024 same day

    Sold 20,000 shares at $164.14 ($3.3M)

    Gangolli Julian S, Director

    No 10b5-1 planSold 100% of holdings ($3.3M position)0 shares leftFirst sale on recordFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (6)

Form 144 notices and Form 4 sales by Gangolli Julian S
Source
May 20, 2024May 22, 2024KRYSDirectorForm 4 sale20,000$3.3M100.0%UnusualSEC
May 20, 2024May 20, 2024KRYSDirectorForm 144 notice20,000$3.3MNoticeSEC
May 10, 2019May 14, 2019GW PHARMACEUTICALS PLCPresident, North AmericaForm 4 sale671,928$10M86.3%UnusualSEC
Feb 26, 2019Feb 28, 2019GW PHARMACEUTICALS PLCPresident, North AmericaForm 4 sale6,000$75k5.3%Plan not statedSEC
Dec 27, 2013Dec 30, 2013ALLERGAN INCCVP & Pres, North AmericaForm 4 sale52,500$5.8M86.7%UnusualSEC
Nov 28, 2012Nov 29, 2012ALLERGAN INCCVP & Pres, North AmericaForm 4 sale90,000$8.3M85.1%UnusualSEC